REVIEW
|
doi:10.20944/preprints202304.1141.v1
Subject:
Medicine And Pharmacology,
Pharmacology And Toxicology
Keywords:
biosimilarity; biosimilars; pharmacodynamic biomarkers; monoclonal antibodies; FDA; clinical efficacy testing in healthy subjects; clinical efficacy testing in patients; functional assays; receptor binding
Online: 28 April 2023 (08:03:20 CEST)